Vinva Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Vinva Investment Management's PFE Position: Q1 2026 in Review
Vinva Investment Management increased its Pfizer (PFE) stake by 5.6% in Q1 2026, buying an estimated $602K and bringing the position to 428,099 shares worth $11.9M. The position accounts for 0.15% of the portfolio, ranked #158.
Vinva Investment Management first reported a position in PFE in Q1 2023 and has held it in 13 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Vinva Investment Management held 428,099 shares of Pfizer worth $11.9M as of Q1 2026.
- Vinva Investment Management bought 22,628 Pfizer shares in Q1 2026, an estimated $602K.
- Pfizer made up 0.15% of Vinva Investment Management's portfolio in Q1 2026, its #158 holding.
- Vinva Investment Management first reported a position in Pfizer in Q1 2023 and has held it in 13 quarters since.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.